Cargando…

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

The occurrence of dyspnoea in acute coronary syndrome (ACS) patients has always been considered a challenging diagnostic and therapeutic clinical scenario. P2Y12 platelet receptor inhibitors (i.e., clopidogrel, prasugrel and ticagrelor) are currently the cornerstone of treatment of ACS patients. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parodi, Guido, Storey, Robert F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Acute Coronary Syndromes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657388/ https://www.ncbi.nlm.nih.gov/pubmed/25267878 http://dx.doi.org/10.1177/2048872614554108

Ejemplares similares

Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2018)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Risk factors for acute coronary syndrome in patients below the age of 40 years
por: Mirza, Aram J., et al.
Publicado: (2018)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Long-term prognostic value of mitral regurgitation in acute coronary syndromes
por: Persson, Anita, et al.
Publicado: (2010)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
por: Youssef, G.S., et al.
Publicado: (2017)

The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome
por: Ang, Donald S C, et al.
Publicado: (2012)

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
por: Banerjee, Debasish, et al.
Publicado: (2019)

Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?
por: Wahab, Mohamed Abdel Kader Abdel
Publicado: (2017)

Patients with non-obstructive coronary artery disease admitted with acute myocardial infarction carry a better outcome compared to those with obstructive coronary artery disease
por: Abdelmonem, Yasser Yazied, et al.
Publicado: (2017)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Al-Jabari, Ali Mohammed Kareem, et al.
Publicado: (2017)

Clinical role of serum Copeptin in acute coronary syndrome
por: Abd El Baky Mahmoud, Manal, et al.
Publicado: (2018)

The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome
por: Li, Wentao, et al.
Publicado: (2023)

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
por: Padfield, Gareth J, et al.
Publicado: (2013)

Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
por: Wei, L, et al.
Publicado: (2008)

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome
por: Di Filippo, Chiara, et al.
Publicado: (2019)

Strategic target temperature management in myocardial infarction—a feasibility trial
por: Testori, Christoph, et al.
Publicado: (2013)

Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
por: Sobhy, Mohamed, et al.
Publicado: (2018)

Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score
por: Morttada, Ayman, et al.
Publicado: (2018)

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
por: Tamita, Koichi, et al.
Publicado: (2012)

Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
por: De Luca, G, et al.
Publicado: (2008)

Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach()()
por: Sultan, El-Zahraa M., et al.
Publicado: (2018)

LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19
por: Quesada, Odayme, et al.
Publicado: (2022)

Death anxiety in patients with myocardial infarction or cancer
por: Şahan, Ebru, et al.
Publicado: (2018)

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Sex Differences in Patient-Reported Outcomes in the Immediate Recovery Period After Resuscitation: Findings From the Cross-sectional DenHeart Survey
por: Wagner, Mette Kirstine, et al.
Publicado: (2023)

Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials
por: Hoedemaker, Niels PG, et al.
Publicado: (2019)

Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
por: Hassan, Kambiz, et al.
Publicado: (2023)

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States
por: Larmore, Cynthia, et al.
Publicado: (2015)

Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017)

LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry
por: Dehghani, Payam, et al.
Publicado: (2023)

Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era
por: Borgaonkar, Sanket, et al.
Publicado: (2021)

Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
por: Banning, Amerjeet S., et al.
Publicado: (2015)

Prevalence and Outcome of Acute Respiratory Distress Syndrome in Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Fan, Tracey H., et al.
Publicado: (2021)

Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?
por: Scarsini, Roberto, et al.
Publicado: (2020)

Angiographic and Procedural Characteristics in Frail Older Patients with Non-ST Elevation Acute Coronary Syndrome
por: Beska, Benjamin, et al.
Publicado: (2023)

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective
por: Greco, Antonio, et al.
Publicado: (2023)

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
por: Ono, Masafumi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qhdpv87o3vh95mpkks0jjq4caf